Observational Medical Outcomes Partnership

The Observational Medical Outcomes Partnership (OMOP) is a public-private partnership designed to help improve the monitoring of drugs for safety. The partnership is conducting a multi-year initiative to research methods that are feasible and useful to analyze existing healthcare databases to identify and evaluate safety and benefit issues of drugs already on the market.

OSIM2 Source Code and Datasets are Available

OMOP has released the second-generation simulated dataset procedure Observational Medical Dataset Simulator (OSIM2). In addition to releasing the source code for the simulator, we are making 16 simulated datasets available for public use. Each dataset is a 10m person dataset modeled after the Thomson Reuters MarketScan® Lab Database, one without any signals injected, and the other 15 databases have different size/types of signals.

Register for the OMOP 2012 Symposium

Register today for the OMOP 2012 Symposium scheduled for June 28, 2012. The final agenda and symposium materials will be posted here closer to the symposium date. We hope to see you on June 28th!

OMOP Presentations and Publications

What to know more about OMOP? Browse around in the OMOP presentations and publications.

Syndicate content